COVID-19 is characterized by a hyperinflammatory state marked by elevated levels of colony-stimulating factors (G-CSF and GM-CSF), inflammatory markers (IL-1β, IL-6, IL-8, and TNF-α), and activated cytokine-tracing agents [83]. The gene discussed is CSF2; the disease is COVID-19.